Media

June 2021 -


"Laborjournal" features Reseaerch and Synendos Startup:


https://www.laborjournal.de/editorials/2268.phpext

December 2020 - 20 Million CHF Funding in Series A for Synendos Therapeutics - a Gertsch group spinout led by Andrea Chicca (CEO). Read the success story:


  • NCCR TransCure
  • University of Bern interview with Jürg Gertsch




November 2018 - Psychoactive cannabinoid in liverwort

  • Psychoactive cannabinoids in liverwort

    Psychoactive cannabinoids in liverwort

    Button

  • Bildtitel

    Selective Endocannabinoid Reuptake Inhibitors (SERIs)

    Read Paper

November 2017 - New pharmacological mechanism in the endocannabinoid system to treat anxiety

Public ourtreach events organized by our lab at the NCCR TransCure, University of Bern



Interview Jürg Gertsch at Swiss Television (SRF) about Endocannabinoid System
Share by: